Significant biosimilar activities this week include:

  • 05 Aug 20: in its Q4 FY20 earnings call, Aurobindo Pharma announced that its wholly owned subsidiary CuraTeQ Biologics intends to file applications for two of its biosimilar products in EU at the end of 2020 or st...

Significant biosimilar activities this week include:

  • May 29: in a filing to the Securities and Exchange Commission, Alexion announced it has settled its eculizumab dispute with Amgen. Under the agreement, Amgen will receive a non-exclusive, royalty-free license to m...

Please reload

Biosimilars bulletin 

November 9, 2020

Please reload

Search by tags